Literature DB >> 7016402

A comparison of the effects of intravenous infusion of individual branched-chain amino acids on blood amino acid levels in man.

S Eriksson, L Hagenfeldt, J Wahren.   

Abstract

1. Intravenous infusions of L-valine (600 mumol/min), L-isoleucine (150 mumol/min), L-leucine (300 mumol/min) and a mixture of the three branched-chain amino acids (70% L-leucine, 20% L-valine, 10% L-isoleucine; 270 mumol/min) were given to four groups of healthy volunteer subjects. Whole-blood concentrations of amino acids and glucose and serum insulin were measured before and during the infusions. 2. Valine and isoleucine infusions resulted in twelve- and six-fold increases in the respective amino acid. During valine infusion, tyrosine was the only amino acid for which a decrease in concentration was seen (25%, P less than 0.05). With isoleucine administration, no significant changes were found. In contrast, leucine infusion (during which the leucine concentration rose about sixfold) was accompanied by significant decreases in tyrosine (35%), phenylalanine (35%), methionine (50%), valine (40%) and isoleucine (55%). The arterial glucose concentration fell slightly (5%) and the insulin concentration increased 20% during leucine infusion. 3. Infusion of the mixture of the three branched-chain amino acids resulted in marked decreases in tyrosine (50%), phenylalanine (50%) and methionine (35%). The decreased amino acid levels remained low for 2 h after the end of the infusion. 4. The present findings demonstrate that intravenous infusion of leucine (not infusion of valine or isoleucine) results in marked reductions in the concentrations of the aromatic amino acids and methionine. Infusion of a mixture of the three branched-chain amino acids gives results similar to those obtained with leucine infusion alone. Thus a mixed branched-chain amino acid solution with leucine as its main constituent seems to be the best alternative in the treatment of patients with hepatic cirrhosis and encephalopathy.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7016402     DOI: 10.1042/cs0600095

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  13 in total

1.  Effects of branched-chain amino acids on plasma amino acids in amyotrophic lateral sclerosis.

Authors:  O Gredal; S E Møller
Journal:  Amino Acids       Date:  1996-03       Impact factor: 3.520

Review 2.  Branched chain amino acids in liver disease: fact or fantasy?

Authors:  D B Silk
Journal:  Gut       Date:  1986-11       Impact factor: 23.059

3.  Evidence for inhibition of exodus of small neutral amino acids from non-brain tissues in hyperphenylalaninaemic rats.

Authors:  C de Cespedes; J G Thoene; K Lowler; H N Christensen
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

4.  Leucine and tissue distribution of bulky and small neutral amino acids in rats: dissociation between transport and insulin-mediated effects.

Authors:  C de Céspedes; J G Thoene; K Lowler; H N Christensen
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

Review 5.  Progress in the treatment of chronic portasystemic encephalopathy.

Authors:  I R Crossley; R Williams
Journal:  Gut       Date:  1984-01       Impact factor: 23.059

6.  Hydrolyzed casein and whey protein meals comparably stimulate net whole-body protein synthesis in COPD patients with nutritional depletion without an additional effect of leucine co-ingestion.

Authors:  Renate Jonker; Nicolaas E P Deutz; Marcia L Erbland; Paula J Anderson; Mariëlle P K J Engelen
Journal:  Clin Nutr       Date:  2013-07-01       Impact factor: 7.324

Review 7.  Observations of branched-chain amino acid administration in humans.

Authors:  Dwight E Matthews
Journal:  J Nutr       Date:  2005-06       Impact factor: 4.798

Review 8.  Leucine supplementation and intensive training.

Authors:  A Mero
Journal:  Sports Med       Date:  1999-06       Impact factor: 11.136

9.  Reduction of large neutral amino acid concentrations in plasma and CSF of patients with maple syrup urine disease during crises.

Authors:  M Wajner; D M Coelho; A G Barschak; P R Araújo; R F Pires; F L Lulhier; C R Vargas
Journal:  J Inherit Metab Dis       Date:  2000-07       Impact factor: 4.982

10.  Effects of branched chain amino acid infusion on glucose metabolism in cirrhotic patients with encephalopathy.

Authors:  S Morioka; K Kanai; M Kako; T Nakajima; T Yoshimi; M Masaka; K Sudo; T Kanno
Journal:  Gastroenterol Jpn       Date:  1983-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.